WO1998014465A1 - 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium and rosa to control ethylene levels in geraniums and roses - Google Patents
1-aminocyclopropane-1-carboxylate synthase genes from pelargonium and rosa to control ethylene levels in geraniums and roses Download PDFInfo
- Publication number
- WO1998014465A1 WO1998014465A1 PCT/US1997/017644 US9717644W WO9814465A1 WO 1998014465 A1 WO1998014465 A1 WO 1998014465A1 US 9717644 W US9717644 W US 9717644W WO 9814465 A1 WO9814465 A1 WO 9814465A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- seq
- nucleotides
- geranium
- acc synthase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8249—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving ethylene biosynthesis, senescence or fruit development, e.g. modified tomato ripening, cut flower shelf-life
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8291—Hormone-influenced development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Definitions
- This invention relates to the field of compositions and methods for inhibiting the enzyme 1-aminocyclopropane-l-carboxylate (ACC) synthase in both geranium and rose thereby prolonging the shelf-life of cut flowers as well as reducing leaf yellowing and petal abscission during shipping and storage.
- ACC 1-aminocyclopropane-l-carboxylate
- Ethylene in all higher plants, is important to plant growth and development from seed germination, seedling growth to flowering and senescence (Abeles, F.B. et al. (1992), In: Ethylene in Plant Biology. Eds. Abeles, F.B. et al, Academic Press, New York, p ⁇ 285-291 and 1-13; Yang, S.F. et al (1984), ⁇ nnw. Rev Plant Physiol 35, 155- 189). Ethylene production in plants can also be associated with trauma induced by mechanical wounding, chemicals, stress (such as produced by temperature and water amount variations), and by disease. Hormones can also stimulate ethylene production.
- Such ethylene also sometimes called “stress ethylene”
- stress ethylene can be an important factor in storage effectiveness for plants.
- exposure of plant tissue to a small amount of ethylene often may be associated with increased production of ethylene by other adjacent plants. This autocatalytic effect may be often associated with losses in marketability of plant material during storage and transportation (Abeles et al, supra; Yang et al, supra).
- the ethylene biosynthetic pathway in plants was established by Adams and Yang (Adams D.O., et al, (1979) Proc. Nat'l Acad Sci USA 76: 170-174)).
- the first step involves the formation of S-adenosyl-L-methionine (AdoMet) from methionine by S- adenosyl-L-methionine synthetase.
- AdoMet is then converted into 1- aminocyclopropane-1-carboxylate (ACC), the direct precursor of ethylene in higher plants.
- ACC deaminase an enzyme which metabolizes ACC, thereby eliminating an intermediate in the biosynthesis of ethylene (Klee, et al, (1991) Cell 3: 1187-1193) (See also Theologis, A., et al. (1993), Cellular and Molecular Aspects of the Plant Hormone Ethylene, p. 19-23). Because ACC deaminase is a bacterial enzyme, it is heterologous, and thus, external to the plant. Thus, it is unlikely that this approach will yield a modification that will be stable from generation to generation.
- Yet another approach involves attempts to genetically inhibit the production of the enzymes involved in the biosynthesis of ethylene or to inhibit the biosynthesis of the enzymes directly.
- This approach has the advantage of not only altering the way the plant itself functions irrespective of external factors but also of presenting a system which reproduces itself, that is, the altered plant's progeny will have the same altered properties for generations to come.
- Initial efforts to better understand the enzymes which catalyze the reactions in the biosynthesis of ethylene have involved the identification and characterization of the genes encoding for AdoMet synthetase, ACC synthase, and ACC oxidase (See also Kende H.., 1993, Annu Rev Plant Physiol Mol Biol 44:283-307).
- ACC synthase sequences have been identified for a number of plants. For instance, ACC synthase sequences have been identified for zucchini (Sato T., et al, (1989) Proc. Natl Acad Sci USA 86:6621-6625), winter squash (Nakajima, N., et al, (1990) Plant Cell Physiol 37:1021-1029), tomato (Van Der Straeten, D., et al, (1990) Proc Natl Acad Sci USA 57:4859-4863); (Rottmann, W.H., et al, (1991) J Mol Biol 222:937-961), apple (Dong, J.G., et al, (1991) Planta 185:38-45), mung bean (Botella, J.R., et al, (1992a) Plant Mol Biol 20:425-436; Botella, J.R., et al, (1993) Gene 123:
- ACC synthase is involved in the ethylene pathway is confirmed by the fact that increased levels of ACC synthase mRNA correlate with an increased activity of ACC synthase in plants during fruit ripening and flower senescence. Similar correlation is also observed in response to exogenous signals caused either by wounding or due to treatment with hormones such as auxin, cytokinin and ethylene. Interestingly, the expression of different classes of ACC synthase occurs from a variety of signals in a many plants, e.g. four different ACC synthase genes have been shown to be differentially expressed in tomato fruit, cell cultures, and hypocotyls during ripening, wounding, and auxin treatment (Olson, D.C, et al (1991) Proc.
- RNA as defined below
- full length cDNA clones were obtained, and all of them could be successfully expressed in an in vitro expression system.
- full length ACC synthase (enzyme) protein is synthesized in vitro.
- even later publications by Arteca's group do not describe the actual in vitro expression of any of the isolated DNA clones.
- the cDNA for the GAC-2 gene was never isolated. Rather, only a partial sequence was merely deduced from the sequence of genomic clones. This is significant because it highlights the difficulty in isolating and thereby identifying full length ACC synthase genes.
- Antisense technology is a well known approach to creating a plant that produces less of a selected protein. Through this technology, a plant is altered by introducing a foreign DNA sequence that encodes an mRNA product complementary to part or all of the plant's "sense" mRNA encoding the protein. The presence of antisense RNA inhibits RNA function within a cell (and whole organism). Antisense RNA can bind in a highly specific manner to its complementary sense RNA resulting in blockade in processing and/or translation of the sense mRNA. Antisense RNA may also disrupt interactions between sense mRNA and sequence-specific RNA binding proteins. Antisense technology may be employed to inhibit the synthesis of an enzyme involved in ethylene biosynthesis.
- antisense RNA in plants as a means to inhibit the synthesis of enzymes has been described by various investigators. Rothstein, et al. (1987) Proc. Natl. Acad. Sci. U.S.A. 84: 8439, found that antisense RNA inhibited nopaline synthase (nos) in tobacco. Smith, C.J.S., et al (1988) Nature 334: 724, reported that antisense RNA inhibited polygalacturonase in tomato. Others have used antisense RNA to inhibit the synthesis of enzymes involved in ethylene formation.
- RNA antisense to ACC synthase in tomato plants Others have expressed antisense RNA to a different ethylene forming enzyme (EFE), ACC oxidase, in carnation and tomato (Michael, M.Z., et al, 1993, In: Pech, J.C., et al, eds., Cellular and Molecular Aspects of the Plant Hormone Ethylene (Kluwer Academic Publishers, pp. 298-302); Hamilton, A.J., et al (1990) Nature 346: 284-287; Gray, et al.
- EFE ethylene forming enzyme
- This invention is based on the discovery and cloning of multiple 1 -amino cyclopropane- 1-carboxylate (ACC) synthase cDNA molecules.
- ACC 1 -amino cyclopropane- 1-carboxylate
- the invention provides a method for genetic modification of geranium and rose plants to control their levels of ethylene.
- the newly discovered DNA sequences, fragments thereof, or combinations of such sequences or fragments are introduced into a plant cell in reverse orientation to inhibit expression of ACC synthase, thereby reducing the levels of endogenous ethylene.
- transgenic plants are to be developed and monitored for growth and development.
- Those plants exhibiting prolonged shelf-life with respect to plant growth, flowering, and/or reduced yellowing of leaves due to reduction in levels of ethylene are to be selected and propagated as premier products with improved properties including reduced leaf yellowing and petal abscission during shipping and storage.
- the present invention is directed to an isolated DNA molecule encoding an ACC synthase enzyme of geranium which DNA molecule hybridizes with pPHSacc41 (SEQ ID NO:l), pPHSacc44 (SEQ ID NO:2), or pPHSacc49 (SEQ ID NO:3), or a functional derivative of the DNA molecule which hybridizes with SEQ ID NO: 1 , SEQ ID NO:2 or SEQ ID NO:3 and to an isolated DNA molecule encoding an ACC synthase enzyme of rose which DNA molecule hybridizes with pRoseKacc7 (SEQ ID NO: 14) or a functional derivative of the DNA molecule which hybridizes with SEQ ID NO: 14.
- the isolated DNA molecule is preferably one with substantial sequence homology with a molecule selected from, for geranium, the group consisting of SEQ ID NO:l, SEQ ID NO:2 and SEQ ID NO:3, and for rose, the molecule set out in SEQ ID NO: 14.
- the isolated DNA molecule is selected from the group consisting of SEQ ID NO:l, SEQ ID NO:2 and SEQ ID NO:3.
- the isolated DNA molecule is that of SEQ ID NO: 14.
- the present invention provides an isolated protein encoded by a DNA molecule as described above, or a functional derivative thereof.
- a preferred protein has an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5 and SEQ ID NO:6, or is a functional derivative thereof.
- a preferred protein has an amino acid sequence of SEQ ID NO: 15 or is a functional derivative thereof.
- an antisense oligonucleotide or polynucleotide encoding an RNA molecule which is complementary to at least a portion of an RNA transcript of the DNA molecules described above, which RNA molecule hybridizes with the RNA transcript such that expression of the ACC synthase enzyme is altered.
- the above antisense oligonucleotide or polynucleotide molecule can be full length or preferably has between six — or ten, twenty, or fifty ⁇ and 100 nucleotides.
- the antisense oligonucleotide or polynucleotide may be complementary to at least a portion of one strand of the nucleotide sequence SEQ ID NO: 1
- the antisense oligonucleotide is complementary to at least a part of a 5' non-coding portion of one strand of the nucleotide sequence SEQ ID NO:l, SEQ ID NO:2 or SEQ ID NO:3.
- the antisense oligonucleotide or polynucleotide may be complementary to at least a portion of one strand of the nucleotide sequence SEQ ID NO: 14 or may be complementary to at least a portion of an RNA sequence encoded by SEQ ID NO: 14. In one embodiment, the antisense oligonucleotide is complementary to at least a part of a 5' non-coding portion of one strand of the nucleotide sequence SEQ ID NO: 14.
- an antisense oligonucleotide as described above may be complementary to at least a part of the nucleotide sequence SEQ ID NO:l or SEQ ID NO:2 or SEQ ID NO:3, which part is, for example, from nucleotides 1-50; nucleotides 51-100; nucleotides 101-150; nucleotides 151-200; nucleotides 201-250; nucleotides 251-300; 301-350; 351-400; 401-450; or 451-500; or any other such contiguous group up to nucleotide 500, 1000, or to the end of the gene.
- an antisense oligonucleotide as described above may be complementary to at least a part of the nucleotide sequence SEQ ID NO:14, which part is, for example, from nucleotides 1-50; nucleotides 51-100; nucleotides 101-150; nucleotides 151-200; nucleotides 201-250; nucleotides 251-300; 301-350; 351-400; 401-450; or 451-500; or any other such contiguous group up to nucleotide 500, 1000, or even to the end of the gene.
- This invention is further directed to a vector useful for transformation of either a geranium or a rose plant cell, comprising: (a) an antisense oligonucleotide or polynucleotide as described above ; (b) regulatory sequences required for expression of the oligonucleotide or polynucleotide in the cell.
- the regulatory sequences comprise a promoter active in the cell, which may be an inducible promoter or preferably, a constitutive promoter.
- the vector preferably further comprise a polyadenylation signal.
- the promoter is preferably a heterologous promoter such as a viral promoter.
- a preferred viral promoter is the CaMV 35S promoter or a promoter homologous to CaMV35S.
- the promoter is selected from the group consisting of the SSU gene promoter, ribulose bisphosphate carboxylase promoter, chlorophyll a/b binding protein promoter, potato ST-LS1 gene promoter, soybean heat shock protein hspl7.5-E promoter, soybean heat shock protein hsp 17.3-B promoter, phenylalanine ammonia-lyase promoter, petunia 5-enolpyruvylshikimate-3-phosphate synthase gene promoter, Rhizobium meliloti FIXD gene promoter and nopaline synthase promoter.
- a geranium cell and a rose cell each transformed with a vector as described above, a plantlet or mature geranium or rose plant generated from such a cell, or a plant part from such plants.
- the present invention is further directed to a method to alter expression of an ACC synthase enzyme in both a geranium cell, plant or a cutting thereof and a rose cell, plant or a cutting thereof, comprising
- Also provided is a method of producing both a geranium and a rose plant having reduced ethylene production compared to an unmodified plant comprising the steps of: (a) transforming either a geranium or a rose plant with a vector as above; (b) allowing the plant to grow to at least a plantlet stage;
- the invention is directed to a method for producing either a geranium or a rose variety (or line), characterized by reduced expression or activity of an ACC synthase enzyme and reduced ethylene production compared to an unmodified geranium or rose variety, comprising producing a geranium or rose plant as above and selfing the plant to generate the variety.
- step (b) constructing a vector which comprises an antisense DNA sequence encoding at least a part of the gene identified in step (a) in an antisense orientation such that
- an RNA transcript of the antisense DNA sequence is complementary to the part of the gene
- step (d) regenerating a plant from the transformed cell of step (c), to produce the variant plant.
- the above method is also used to produce a plant variety in a non-geranium or non-rose plant species characterized by reduced expression or activity of an ACC synthase enzyme and reduced ethylene production compared to a conventional variety of the species, comprising producing a variant plant as above, and selfing the plant to generate the variety.
- This invention also provides a method for genetically altering a plant, preferably (but not necessarily) a plant of a low RNA species, comprising the steps of:
- the plant is preferably a species of the genus Pelargonium or Rosa.
- the cloned DNA sequence preferably encodes ACC synthase.
- the cDNA in the above method is preferably selected from the group consisting of SEQ ID NO:l, SEQ ID NO:2 and SEQ ID NO:3 for geranium, and SEQ ID NO: 14 for rose. The above method is used to produce a genetically altered geranium or rose plant, comprising the steps of:
- the invention is further directed to a method of isolating plant mRNA, comprising the steps of:
- RNA from the nucleic acids of step (a) using a 2-butoxyethanol precipitation technique
- a binding partner for mRNA for example oligo-dT or another molecule or entity which has the characteristics of binding specifically to mRNA with the exclusion of other forms of RNA or DNA.
- the binding partner may be immobilized on a solid phase or carrier; this yields immobilized mRNA; and (d) eluting the immobilized mRNA from the carrier by conventional elution methods, or obtaining bound mRNA, thereby isolating the mRNA from total RNA.
- Figure 1 shows the ethylene biosynthetic pathway including the step catalyzed by ACC synthase.
- FIG. 2 is a diagram showing the details of steps of cDNA synthesis from mRNA
- Figure 3 shows the nucleotide sequence of the cDNA clone designated pPHSacc41 (SEQ ID NO:l). The following landmarks are indicated: the short 5' sequence originating in the vector are in italics and underscored; the start ATG codon is in bold and underscored; the termination codon of the coding sequence (TAA or TAG) is in bold and double underscored; the polyadenylation signal (sequence) near the 3' end is shown in bold (AATAAA or AAATAA).
- Figure 4 shows the nucleotide sequence of the cDNA clone designated pPHSacc44 (SEQ ID NO:2). Landmarks are as shown in figure 3.
- Figure 5 shows the nucleotide sequence of the cDNA clone designated pPHSacc49 (SEQ ID NO:3). Landmarks are as shown in figure 3.
- Figure 6 shows the deduced amino acid sequence (SEQ ID NO:4) encoded by nucleotide sequence SEQ ID NO: l.
- Figure 7 shows the deduced amino acid sequence (SEQ ID NO: 5) encoded by nucleotide sequence SEQ ID NO:2.
- Figure 8 shows the deduced amino acid sequence (SEQ ID NO: 6) encoded by nucleotide sequence SEQ ID NO:3.
- Figure 9 shows the nucleotide sequence of the cDNA clone designated pRoseKacc7 (SEQ ID NO: 14). The following landmarks are indicated: the start ATG codon is in bold and underscored; the termination codon of the coding sequence (TAG) is in bold and double underscored.
- Figure 10 shows the deduced amino acid sequence (SEQ ID NO: 15) encoded by nucleotide sequence SEQ ID NO: 14.
- the present inventor has isolated, cloned and identified several cDNA sequences encoding the enzyme ACC synthase in both geranium and rose plants (specifically from Pelargonium hortorum cv Sincerity and Rosa). These cDNA sequences correspond to genes which are important in the control of ethylene production.
- the DNA is expressed in any of a number of expression systems, including an in vitro expression system to yield a polypeptide product which preferably has ACC synthase enzymatic activity.
- Cloned ACC synthase gene(s) or fragments thereof when introduced in reverse orientation (antisense) under control of a strong promoter (discussed below in detail) , such as the cauliflower mosaic virus promoter CaMV35S, can be used to genetically modify either a geranium or a rose plant. Selected antisense sequences sharing sufficient homology to ACC synthase genes in other plants can be used to achieve similar genetic modification.
- a strong promoter discussed below in detail
- Selected antisense sequences sharing sufficient homology to ACC synthase genes in other plants can be used to achieve similar genetic modification.
- One result of this modification is a reduction in the amount of translatable ACC synthase-encoding mRNA. As a consequence, the amount of ACC synthase produced in the plant cells is reduced, thereby reducing the rate of conversion of ACC to ethylene.
- This genetic modification can effect a permanent change in ethylene levels in the modified plant and be propagated in offspring plants by selfing or other reproductive schemes.
- the invention provides a plant modified as described herein as well as plants which, although modified in a different manner achieve similar results or utilize similar concepts as disclosed herein.
- the genetically altered plant is used to produce a new variety or line of plants wherein the alteration is stably transmitted from generation to generation.
- the geranium plant is one of the most ethylene-sensitive flowering plants (Nell,
- the present invention provides isolated ACC synthase genes obtained specifically from geranium for use in genetic modification preferably of geranium plants and isolated ACC synthase genes obtained specifically from rose for use in genetic modification preferably of rose plants.
- the full length DNA molecules described herein are unique to geraniums and to roses and vary significantly in sequence from ACC synthase DNA in any other unrelated plant species.
- an ACC synthase gene or gene fragment (a) be obtained from the same species or (b) be a functional derivative of the DNA sequence native to the species.
- a selected sequence from one plant genus or species may be employed using antisense technology in a different genus or species to achieve a useful effect such as that described here.
- the present invention thus provides for the first time the appropriate DNA sequences which may be used to achieve a stable genetic modification primarily of geranium and rose plants (and of other plants as well).
- the term "plant” refers to either a whole plant, a plant part, a plant cell, or a group of plant cells.
- the types of plants which can be used in the method of the invention generally includes the genus Pelargonium (geraniums) and the genus Rosa (roses) which can take up and express the DNA molecules of the present invention. It may include plants of a variety of ploidy levels, including haploid, diploid, tetraploid, and polyploid.
- a "transgenic plant” is defined as a plant which is genetically modified in some way, including but not limited to a plant which has incorporated heterologous DNA or modified DNA or some portion of heterologous or homologous DNA into its genome.
- the altered genetic material may encode a protein, comprise a regulatory or control sequence, or may comprise an antisense sequence or encode an antisense RNA which is antisense to an endogenous DNA or mRNA sequence of the plant.
- a "transgene” or a" transgenic sequence” is defined as a foreign or atypical gene or partial sequence which has been incorporated into a transgenic plant.
- sequence homology or “substantially homologous” is used to indicate that a nucleotide sequence (in the case of DNA or RNA) or an amino acid sequence (in the case of a protein or polypeptide) exhibits substantial functional or structural equivalence with another nucleotide or amino acid sequence. Any functional or structural differences between sequences having substantial sequence homology will be de minimis; that is, they will not affect the ability of the sequence to function as indicated in the desired application. Differences may also be simply due to inherent variations in codon usage among different species. Sequences that have substantial sequence homology with the sequences disclosed herein are usually "variants" of the disclosed sequence, such as mutations, but may also be synthetic sequences.
- Structural differences are considered de minimis if there is a significant amount of sequence overlap or similarity between two or more different sequences or if the different sequences exhibit similar physical characteristics even if the sequences differ in length or structure. Such characteristics include, for example, ability to hybridize under defined conditions, or, in the case of proteins, immunological crossreactivity, similar enzymatic activity, etc.
- two nucleotide sequences are substantially homologous if the sequences have at least 70 percent, more preferably 80 percent and most preferably 90 percent sequence similarity between them.
- Two amino acid sequences are substantially homologous if they have at least 50 percent, preferably 70 percent, and most preferably 90 percent similarity between the active portions of the polypeptides.
- hybridization is generally understood to mean hybridization at appropriate conditions of stringency as would be readily evident to those skilled in the art depending upon the nature of the probe sequence and target sequences.
- Conditions of hybridization and washing are well-known in the art, and the adjustment of conditions depending upon the desired stringency by varying incubation time and temperature and ionic strength of the solution are readily accomplished. See, for example, Sambrook, J., et al, Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Press, Cold Spring Harbor, NY (1989).
- the choice of conditions is dictated by the length of the sequences being hybridized, in particular the length of the probe sequence, the relative G-C content of the nucleic acid and the amount of mismatches to be permitted.
- Low stringency conditions are preferred when partial hybridization between strands that have lesser degrees of complementarity is desired.
- high stringency conditions are preferred.
- the hybridization solution contains 6X SSC, 0.01M EDTA, 5X Denhardt's solution and 0.5% SDS.
- Hybridization is carried out at about 68 °C for 3-4 hours for fragments of cloned DNA and 12-16 hours for total eukaryotic DNA.
- the temperature is reduced to about 12 °C below the melting temperature (T m ) of the duplex.
- T m is known to be a function of G-C content and duplex length as well as the ionic strength of the solution.
- a functional derivative of a nucleic acid is meant a “fragment,” “variant,” “homologue” or “analogue” of the gene or DNA sequence encoding ACC synthase, or in some way related to the production or use of ACC synthase, especially geranium or rose ACC synthase.
- a functional derivative may retain at least a portion of the function of the ACC synthase-encoding DNA which permits its utility in accordance with one embodiment of the present invention.
- Such function may include the ability to hybridize with native geranium, native rose, or homologous DNA from another plant which encodes ACC synthase or with an mRNA transcript thereof, or, in antisense orientation, to inhibit the transcription and/or translation of geranium ACC synthase mRNA, rose ACC synthase mRNA, or the like.
- a "fragment" of the gene or DNA sequence refers to any subset of the molecule, that is, a shorter polynucleotide- or oligonucleotide.
- a “variant” refers to a molecule substantially similar to either the entire gene or a fragment thereof, such as a nucleotide substitution variant having one or more substituted nucleotides but which maintains the ability to hybridize with the particular gene or to encode a mRNA transcript which hybridizes with the native DNA.
- a “homologue” refers to a fragment or variant sequence from a different plant genus or species.
- An “analogue” refers to a non-natural molecule substantially similar to or functioning in relation to either the entire molecule, the variant, or to a fragment thereof.
- altered expression or an “alteration” of expression of a gene (most particularly of ACC synthase), as used herein, refers to any process or result whereby the normal expression of the gene, for example that occurring in an "unmodified” geranium or rose plant, defined as a known, conventional, naturally-occurring geranium or rose plant, is changed in some fashion.
- an alteration is a complete or preferably a partial reduction in the expression of ACC synthase, but may also include a change in the timing of expression, or another state wherein the expression of ACC synthase differs from that which would be most likely to occur naturally in an unmodified geranium or rose plant, variety or cultivar.
- a preferred alteration is one which results in a decrease in ethylene production by the plant compared to ethylene production in an unmodified plant.
- ACC synthase In producing a genetically altered plant according to this invention, it is preferred to select individual plantlets or plants by the desired trait, generally reduced ACC synthesis expression and reduced ethylene production.
- Expression of ACC synthase can be measured by quantitating the amount of ACC synthase mRNA using conventional hybridization techniques.
- the amount of ACC synthase protein can be quantitated, for example in a conventional immunoassay method using a specific antibody such as those described herein.
- the ACC synthase enzymatic activity can be measured using biochemical methods as described in Kionka et al, supra; Amrhein et al, supra; or Hoffman N.E., et al, supra.
- Ethylene biosynthesis in the plantlet or plant can be quantitated using known methods Yang, S.F. et al. (1984), Annu. Rev Plant Physiol:35, 155-189); Abeles, F.B. et al. eds, Ethylene in Plant Biology, Academic Press, New York, 1976White, J.W., ed., Geranium IV. The Growers Manual, Edition Four, Ball Publishing, Geneva, IL.
- the proper regulatory signals should be present in the proper location with respect to the coding or antisense sequence.
- These regulatory signals may include a promoter region, a 5' non-translated leader sequence and a 3' polyadenylation sequence as well as enhancers and other known regulatory sequence.
- the promoter is a DNA sequence that directs the cellular machinery to transcribe the DNA to produce RNA.
- the promoter region influences the rate at which the mRNA product and, if the DNA encodes a protein, the resultant protein product, are made.
- the 3 '-polyadenylation signal is a non-translated region that functions in plant cells to cause the addition of a polyadenylate stretch to the 3 ' end of the mRNA to stabilize it in the cytoplasm for subsequent translation.
- a promoter DNA sequence is operably linked to a second DNA sequence and regulates its transcription. If the second DNA sequence encodes a protein, the promoter DNA sequence is said to be “operably linked” if it affects the transcription of the mRNA encoding the protein product from the second DNA sequence.
- a DNA sequence comprising a promoter is generally physically near the coding sequence in the same recombinant construct, though physical contiguity is not required. "Strong" promoters are able to direct RNA synthesis at higher rates than weaker promoters. Certain promoters direct RNA production at higher levels only in particular types of cells and tissues.
- constitutive promoters Promoters that direct RNA production in many or all tissues of a plant without the need for "induction" by a specific inducer substance are called constitutive promoters.
- the operation of a constitutive promoter is relatively independent of the developmental stage of the cell in which it is contained and is most preferred for the present invention.
- An inducible promoter is one which, in response to the presence of an inducer, is activated.
- a coding sequence driven by an inducible promoter can be turned on or off by providing or withdrawing the inducer.
- a promoter may be homologous, derived from the same species as the coding sequence.
- the promoter is heterologous, that is, derived from another species, or even from a virus.
- Expression levels from a promoter which is useful for the present invention can be tested using conventional expression systems, for example, by measuring levels of a reporter gene product (protein or mRNA) in extracts of the leaves, stems, roots and flowers of a transgenic plant into which the promoter/reporter have been introduced.
- a reporter gene product protein or mRNA
- Cauliflower mosaic virus is a double-stranded DNA plant virus. It contains two promoters responsible for the production of transcripts of 35S and 19S in size in infected plants (Guilley, H., et al, Cell 30:763 (1982)).
- the 35S promoter (CaMV35S) is one of the strongest constitutive heterologous promoters known in plants (Odell, et al, Nature 313:810-812 (1985); Jensen, et al, Nature 321:669-674 (1986); Jefferson, et al, EMBO J. 5:3901-3907 (1987); Kay, et al, Science 236:1299-1302 (1987); Sanders, et al, Nucl.
- Two different domains within the CaMV 35S promoter may differentially regulate expression of a coding sequence in different plant tissues (domain A, from nucleotides -90 to +8) vs. domain B from nucleotides - 343 to -90) , as described by Benfey, et al, 1989 EMBO J. 5:2195-2202. )
- the CaMV35S promoter is active in isolated protoplasts (Fromm, M., et al, Proc. Natl Acad. Sci. USA 82:5824 (1985)) and is expressed in all organs of various transgenic plants in the absence of any viral protein, making it widely used in plant genetic engineering.
- CaMV35S may be particularly useful for effecting different degrees of altered gene expression by an antisense sequence which the promoter controls.
- Additional useful plant promoters in, for example, other caulimoviruses a group of double-stranded DNA viruses to which the cauliflower mosaic virus belongs
- FMV figwort mosaic virus
- Certain other strong plant promoters are also useful to direct the expression of the ACC synthase DNA (or antisense sequences) of the present invention.
- the small subunit (SSU) of the enzyme ribulose- 1,5-bisphosphate carboxylase (RuBPCase), the primary enzyme of the carbon fixation pathway in chloroplasts of plants of the C3 class is an example of a polypeptides known to be highly expressed in plants.
- a highly efficient SSU promoter DNA such as the promoter DNA from the SSU gene denominated SSU301 from Petunia (Bedbrook, et al, U.S. Patent No. 4,962,028) may be used herein.
- the promoter may be used in the form of an isolated 5' fragment of the SSU gene, and preferably has the 3' end of the fragment modified to create a restriction site which permits ready fusions with the ACC synthase antisense DNA of the present invention.
- the promoter may be conveniently arranged to form an expression cassette comprising a 5' fragment (the promoter region of the SSU gene), a 3' fragment and a linker region connecting the two fragments.
- the fusion points between the 5' fragment and the linker region and between the 3' fragment and the linker region are preferably modified to create restriction sites which permit the antisense DNA of the present invention to be substituted for the linker so as to yield "chimeric" genes containing the complete proximal 5' and 3' regions of the SSU gene but none of the SSU coding sequence
- E. coli ⁇ -glucuronidase (GUS) coding sequence or a mutant Arabidopsis EPSP synthase gene which encodes an enzyme tolerant of glyphosate herbicides may be used as a reporter gene.
- GUS E. coli ⁇ -glucuronidase
- a mutant Arabidopsis EPSP synthase gene which encodes an enzyme tolerant of glyphosate herbicides may be used as a reporter gene.
- Transformed plant cells or plants containing the GUS gene operably linked to the promoter being tested are assayed using a histological staining procedure to determine GUS activity in the transformed cells.
- the present invention provides antisense oligonucleotides and polynucleotides complementary to the gene or genes encoding ACC synthase in geranium or rose plants.
- antisense oligonucleotides should be at least about six, ten, twenty, or fifty nucleotides in length to provide minimal specificity of hybridization, and may be complementary to one strand of DNA or to mRNA encoding ACC synthase (or to a portion thereof), or to flanking sequences in genomic DNA which are involved in regulating ACC synthase gene expression.
- the antisense oligonucleotide may be as large as about 100 nucleotides, an may extend in length up to and beyond the full coding sequence for which it is antisense.
- the oligonucleotides can be DNA or RNA or chimeric mixtures or derivatives or modified versions thereof, single-stranded or double- stranded.
- antisense nucleotide may result in specific alteration, primarily inhibition, of ACC synthase gene expression in cells.
- antisense see: Alberts, B., et al, MOLECULAR BIOLOGY OF THE CELL, 2nd Ed.,
- the antisense oligonucleotide may be complementary to any portion of the ACC synthase encoding sequence.
- the antisense oligonucleotide may be between about 6, 10, 20, or 50 and 100 nucleotides, and may be complementary to the initiation ATG codon and an upstream, non-coding translation initiation site of the ACC synthase sequence.
- antisense nucleotides complementary primarily for non-coding sequence are known to be effective inhibitors of the expression of genes encoding transcription factors (Branch, M.A., 1993 Molec. Cell Biol 73:4284-4290).
- Preferred antisense oligonucleotides are complementary to a portion of the mRNA encoding ACC synthase. For instance, it is expected that by introducing a full length cDNA clone gene in an antisense orientation, successful alteration of gene expression will be most probable. Naturally, introduction of partial sequences, targeting to specific regions of the gene, and the like can be effective as well.
- An example of a preferred antisense oligonucleotide for geranium is a 50mer which is antisense to 50 nucleotides in the 5' half of an RNA transcript of an ACC-encoding cDNA (such as SEQ ID NO:l, SEQ ID NO:2 or SEQ ID NO:3), more preferably any stretch of 50 nucleotides in the first 500 nucleotides of the 5 ' part of the RNA transcript.
- An example of a preferred antisense oligonucleotide for rose is similarly a 50mer which is antisense to 50 nucleotides in the 5' half of an RNA transcript of an ACC-encoding cDNA (such as SEQ ID NO:14), more preferably any stretch of 50 nucleotides in the first 500 nucleotides of the 5' part of the RNA transcript.
- the antisense oligonucleotide can be antisense to nucleotides 1-50, 2-51, 3-52, 4-53,5-54, etc., of the RNA transcript.
- the antisense oligonucleotide can be shorter for wither plant, for example a 30-mer, and be antisense to any 30 nucleotide stretch of the RNA transcript, preferably in the first 500 5' nucleotides.
- the minimal amount of homology required by the present invention is that sufficient to result in sufficient complementarity to provide recognition of the specific target RNA and inhibition or reduction of its translation or function while not affecting function of other mRNA molecules and the expression of other genes.
- the antisense oligonucleotides of the invention comprise sequences complementary to at least a portion of an RNA transcript of ACC synthase, absolute complementarity, although preferred, may not be required.
- a sequence "complementary to at least a portion of another sequence, as referred to herein, may have sufficient complementarity to be able to hybridize with that of other sequences in vivo, perhaps forming a stable duplex.
- the ability to hybridize may depend on both the degree of complementarity and the length of the antisense nucleic acid. Generally, the longer the hybridizing nucleic acid, the more base mismatches with the ACC synthase target sequence it may contain and still form a stable duplex.
- One skilled in the art can ascertain a tolerable degree of mismatch by use of standard procedures to determine the melting temperature of the hybridized complex as discussed above and other techniques.
- antisense RNA oligonucleotides may be generated intracellularly by transcription from exogenously introduced nucleic acid sequences.
- antisense RNA may be delivered to a cell by transformation or transfection or infection with a vector, such as a plasmid or a virus, into which is incorporated (a) DNA encoding the antisense RNA and operably linked thereto (b) the appropriate regulatory sequences, including a promoter, to express the antisense RNA in a target host cell (and whole plant).
- a vector such as a plasmid or a virus
- the exogenous DNA or a portion thereof may be transcribed, producing an antisense RNA of the invention.
- Vectors can be plasmid, viral, or others known in the art which are used for replication and expression in plant cells.
- Expression of the sequence encoding the antisense RNA can be by any promoter known in the art to act in plant, preferably geranium or rose, cells. Such promoters can be inducible or preferably are constitutive as described above.
- a vector preferably a plasmid, becomes chromosomally integrated such that it can be transcribed to produce the desired antisense RNA.
- plasmid or viral vectors can be constructed by recombinant DNA technology methods that are standard in the art.
- An oligonucleotide between about 6 and about 100 bases in length and complementary to the target sequence of ACC synthase, as described above may be prepared by chemical synthesis from mononucleotides or shorter oligonucleotides, or produced by recombinant means.
- Basic procedures for constructing recombinant DNA and RNA molecules in accordance with the present invention are disclosed by Sambrook, J., et al, In: Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Press, Cold Spring Harbor, NY (1989), which reference is herein incorporated by reference.
- Oligonucleotide molecules having a strand which encodes antisense RNA complementary to an ACC synthase sequence can be prepared using procedures which are well known to those of ordinary skill in the art. Details regarding such procedures are described in: Belagaje, R., et al, J. Biol. Chem. 254:5765-5780 (1979); Maniatis, T., et al, In: MOLECULAR MECHANISMS IN THE CONTROL OF GENE EXPRESSION, Nierlich, D.P., et al , eds., Acad. Press, N.Y. (1976); Wu, R., et al, Prog. Nucl. Acid Res. Molec.
- Automated synthesizers may be used for DNA synthesis (such as are commercially available from Biosearch, Applied Biosystems, etc.).
- the transgenic plants of the present invention may be prepared by DNA transformation using any method of transformation known in the art. These methods include transformation by direct infection or co-cultivation of plants, plant tissue or cells with Agrobacterium tumefaciens (Horsch, et al, Science 225:1229 (1985); Marton, Cell Culture and Somatic Cell Genetic of Plants 7:514-521 (1984)); Fry, et al, Plant Cell Reports (5:321-325 (1987); direct gene transfer into protoplasts or protoplast uptake (Paszkowski, et al, EMBO J. 72:2717 (1984); Loerz, et al, Mol & Gen. Genet.
- the Agrobacterium tumefaciens strain 208 carrying the disarmed pMP90RK plasmid can be used to achieve transformation.
- the vector plasmid may be introduced into the Agrobacterium by the triparental conjugation system (Ditta, et al, (1980) Proc. Natl Acad. Sci. USA 77:7347-7451) using the helper plasmid pRK2013.
- the vectors may be transferred to plant cells by the vir functions encoded by the disarmed pMP90RK Ti plasmid.
- the vector is opened at the pTiT37 right border sequence and the entire vector sequence is inserted into the host plant chromosome.
- the pMP9ORK Ti plasmid is probably not transferred to the plant cell but remains in the Agrobacterium.
- regeneration means growing a whole plant from a plant cell, a group of plant cells, a plant part or a plant piece (e.g. from a protoplast, callus, tissue part, or explant, etc.) Plant regeneration from cultured protoplasts is described in Evans, et al, Handbook of Plant Cell Cultures 7:124-176 (MacMillan Publishing Co. New York 1983); Davey, M.R., Protoplasts (1983), Lecture Proceedings, pp.12-29, Birkhauser, Basel, 1983); PJ. Dale, ibid, at pp. 31-41, (Birkhauser, Basel 1983); andH. Binding, Plant Protoplasts, pp.21-73, CRC Press, Boca Raton, 1985).
- Plant parts obtained from the regenerated plant in which expression of an ACC synthase gene has been altered such as flowers, seeds, leaves, branches, fruit, and the like are included within the definition of "plant” as stated above, and are included within the scope of the invention. Progeny and variants and mutants of the regenerated plants are also included, especially if these parts comprise the introduced DNA sequences.
- the present invention also provides ACC synthase proteins encoded for by the cDNA molecules described above.
- such proteins preferably have the amino acid sequences SEQ ID NO:4, SEQ ID NO:5 or SEQ ID NO:6 as shown in figures 6, 7, and 8.
- SEQ ID NO: 15 amino acid sequence of SEQ ID NO: 15 as shown in figure 10.
- these proteins, or functional derivatives thereof, are preferably produced by recombinant methods optionally in combination with chemical methods.
- a “functional derivative” of the ACC synthase protein is a "fragment,” “variant,” “analog,” or “chemical derivative” of ACC synthase, which retains at least a portion of the function of the ACC synthase which permits its utility in accordance with the present invention. Such function includes enzymatic activity or immunological crossreactivity with an antibody specific for ACC synthase.
- a fragment of the ACC synthase protein refers to any subset of the molecule, that is, a shorter peptide.
- a variant refers to a mole- cule substantially similar to either the entire protein or a fragment thereof.
- Variant peptides may be conveniently prepared by direct chemical synthesis using methods well- known in the art.
- an "analog" of ACC synthase refers to a non-natural protein substantially similar to either the entire protein or a fragment thereof.
- a chemical derivative of ACC synthase contains additional chemical moieties not normally a part of the protein or peptide fragment thereof.
- Covalent modifications of an ACC synthase peptide are included within the scope of this invention. Such modifications may be introduced into the molecule by reacting targeted amino acid residues of the peptide with an organic derivatizing agent that is capable of reacting with selected side chains or terminal residues.
- a protein or peptide according to the present invention may be produced by culturing a cell transformed with a DNA sequence of this invention, allowing the cell to synthesize the protein, and obtaining the protein from the culture medium if it is secreted, or if it is intracellular, obtaining it by extraction.
- the protein is produced in a cell free system, for example, as described by Ranu, R.S., et al, 1979, Meth. Enzymol (50:459-484 and Ranu, R.S., et al, (1996) Gene Expression 5:143-153.
- the in vitro translation product or the cell or tissue extract from transformed plant cells or plant parts is subjected to conventional biochemical purification methods, including but not limited to affinity chromatography using an antibody specific for an epitope of the protein.
- the quality of the mRNA largely determines the quality of cDNA library generated subsequently for cDNA cloning of ACC synthase genes.
- quality of the mRNA is intended the presence of all the desired mRNA species, especially those mRNA molecules that are present in cells in relatively low abundance (either because of the number of gene copies, the rate of transcription or the stability of the mRNA).
- the most widely used method for preparation of RNA utilizes extraction with 4 M guanidine thiocyanate of total RNA (Chomczynski, P., et al (1987), Anal. Biochem.. 162:156-159).
- RNA precipitation technique This technique was originally developed for RNA isolation, and by adapting it for mRNA isolation, the extraordinary results of this invention were achieved. Generally, in order to achieve the required RNA precipitation, a co-precipitation critical mass of RNA must be present in the preparation.
- RNA preparation The relative low proportion of RNA in relation to the total extracted material required the recognition by the present inventor that the standard amount of tissue extract used in RNA preparation, about 1 gram or less, would be insufficient for certain types of plants such as geranium and rose (discussed more fully below).
- tissue extract used in RNA preparation
- the success described herein was ultimately attained by using an unusually large amount of tissue. For effort with geranium, this was about 3-5 grams. For effort with rose, this was also about 3-5 grams. While, in hindsight, this may seem like a simple problem and solution, in fact, this problem does not appear to have been considered by others, and, therefore, the novel method is not an obvious modification of the older technique.
- RNA is particularly important to the class of plants which have a low proportion of RNA in their tissue, such as less than only 1/10,000th of the total tissue usually obtained. It is also particularly important for woody plants such as geranium or rose, for which the present invention is particularly useful. These groups of plants comprises plant species that have a low proportion of RNA in their tissue relative to non- nucleic acid material. This is in contrast to other plants which have a higher proportion of RNA and are amenable to the preparation of high quality mRNA (and cDNA corresponding thereto) by the traditional approaches of the prior art.
- RNA low RNA
- plants While this "low RNA” group of plants is known to include at least Pelargonium species and Rosa (rose) species, it is clear that other plants also fall in this category, as would be evident to those skilled in the art.
- This group of plants is characterized in one manner as being woody (that is, they contain large amounts of fiberous material) and therefore having a low relative abundance of RNA, or conversely, as a high relative proportion of non-nucleic acid material.
- a "large” amount of tissue namely, an amount which (depending upon the particular plant or technique) is sufficient to yield a co-precipitant critical mass of lotal RNA in the process.
- RNA isolation techniques or plants may, of course, each have their own critical mass, that is, the presence of enough total RNA for precipitation to actually occur.
- critical mass for the present technique and plants, about 3-5 grams of flower tissue was used initially. This may represent a minimum amount for some plants. Naturally more would also work.
- the flower tissue was ground into a powder using a pestle and mortar precooled by liquid nitrogen.
- the resulting material was then ground with 12-20 ml of extraction buffer (0.2M boric acid/Tris-HCl and 10 mM EDTA (pH 7.6)), followed by addition of 0.24-0.4 ml of 25% sodium dodecyl sulfate (SDS) and 0.24-0.4 ml of 2-mercaptoethanol (2-ME).
- the mixture was brought to room temperature and extracted with an equal volume of extraction buffer, saturated phenol/chloroform mixture.
- the mixture was centrifuged at 20,000xg at room temperature.
- the upper aqueous phase was collected and kept in a fresh tube.
- the interphase and lower organic phase were re-extracted with an equal volume of extraction buffer containing SDS and 2-ME.
- the second aqueous phase was removed and combined with the first aqueous phase.
- the pooled aqueous phase was diluted with 2.5 volume of water and a quantity of IM sodium acetate (pH 4.5) sufficient to make the final concentration 80 mM.
- PolyA + mRNA was isolated by binding to Dynabeads-oligo(dT)25 (Dynal, Inc., Lake Success, NY).
- the oligo (dT)25 is a preferred binding partner, in addition others are known in the art, the key function being merely the ability to selectively attach to the mRNA.
- the protocol provided by the manufacturer was used.
- PolyA + RNA was bound to Dynabeads in the presence of lx binding buffer for 30 minutes.
- the Dynabeads serve as one of the many possible solid phase supports or carriers. This served to immobilize the mRNA.
- the beads were washed three times with washing buffer containing lithium dodecyl sulfate (LiDS) and once with wash buffer alone. mRNA was eluted from the beads with 50 ⁇ l of TE buffer.
- LiDS lithium dodecyl sulfate
- composition of the buffers was as follows:
- the mRNA preparation (5 ⁇ g) isolated as above was used to synthesize cDNA using the ZAP Express® cDNA synthesis system from Stratagene (La Jolla, CA). The details of the steps of synthesis are presented in Figure 2.
- the first strand synthesis was carried out with murine-Moloney leukemia virus reverse transcriptase (M-MuLV-RT) in the presence of mRNA, a primer containing a 50 base long oligonucleotide
- the first strand has methyl groups on each cytosine base which protects cDNA from restriction enzymes used in subsequent cloning steps.
- RNase H nicks the RNA bound to the first strand cDNA to produce multiple fragments which serve as primers for DNA polymerase I (Poll).
- Poll nick-translates the RNA fragments into second strand of cDNA.
- the cDNA ends are blunted in the presence of Klenow fragment and dNTPs.
- the EcoRI adaptors as shown below 5 ' AATTCGGCAGAG- 3 ' [SEQ ID NO:8]
- cDNA is size fractionated on Sephacryl-S400® and then ligated to the ZAP Express Vector® arms. Only cDNA of 1.5 kb pairs was used to ligate into ZAP Express Vector® and then packaged into bacteriophages using Gigapack® III Gold Packaging extract protocol from Stratagene. The unamplified cDNA library generated in this way was used for subsequent screening for ACC synthase genes.
- the first strand of cDNA synthesis was carried out with 2 ⁇ g of mRNA using the ready-to-go T-Primed First-Strand synthesis protocol obtained from Pharmacia
- PCR amplification (Mullis, K.B., et al, F.A. (1987), Meth. Enzymol. 155:355-350) was performed in a Techne PHC-2 Thermocycler (Techne,
- Primer I 5 '-GGIC/TTICCIGGITTC/TC/AGIG/ATIGG-3 '
- the PCR reaction (50 ⁇ l) contained 5mM Tris-HCl (pH 8.3); 3mM MgCl 2 , 50mM
- KCl 50 pmol of primer I: 3 ⁇ l of synthesized first strand cDNA, 200mM each of the four dNTPs and 25 units of- (DELTA) Taq DNA polymerase (Amersham Life Sciences, Inc., Arlington Heights, IL). Reaction samples were overlaid with 20 ⁇ l of mineral oil. After an initial denaturation at 95 °C for 4 minutes, samples were subjected to two cycles in which conditions were 94 °C for one minute for denaturation, 60 °C for two minutes for annealing; and 72 °C for one minute for extension. It was followed by 30 cycles at 94°C for 30 seconds; 60°C for one minute; and 72°C for 45 seconds. The last cycle was at 72 °C for 5 minutes.
- the amplified DNA showed a DNA band of about 360 bp.
- the band was localized in the gel under a UV lamp and excised.
- DNA from the gel was purified by using Spin-Bind Recovery system from FMC BioProducts (Rockland, ME).
- the DNA was then cloned using the protocol provided by manufacturer into a TA Cloning Vector called pCRII (Invitrogen, San Diego, CA) and then sequenced.
- the 360bp fragment cloned in the pCRII vector was excised and used to prepare a [ 32 P]-labeled probe.
- the Maga Prime system from Amersham Life Science, Inc. (Arlington Heights, IL) was used according to the manufacturer's protocol.
- the labeled DNA probe incorporated nearly 70% of the input [ ⁇ 32 P]dATP.
- [ 32 P] labeled probe Phages (50,000 pfu) were grown on a 150-mm NZY plate for six hours at 37°C. The plates were cooled to 4°C Phages were transferred onto a Hybond- N+ nylon membrane (Amersham, Inc.) for 40 seconds. The DNA on membrane was denatured by treatment with 1.5 M NaCl-0.5M NaOH for 2 minutes, neutralized in 1.5M NaCl-0.5M Tris-HCl (pH 8.0) for 5 minutes and finally washed in 0.2 M Tris-HCl (pH 7.5), 2 x SSC for 30 seconds. DNA was fixed onto the membrane by UV cross-linking (Strategene UV Cross-Linker) and then baked at 80 °C for one hour.
- UV cross-linking Strategene UV Cross-Linker
- the membrane was treated with Rapid-hyb® buffer (Amersham, Inc.) at 55 °C for one hour for prehybridization and then probed with [ 32 P]-labeled PCR probe for 3 hours at 55 °C
- the membranes were washed with 2 x SSC-0.1% SDS for one hour at room temperature and with 0.2-x SSC-0.1% SDS at room temperature.
- the filters were then exposed to X ray film (Fuji).
- the dideoxy chain termination method (Sanger, F., et al, (1977), Proc. Natl. Acad. Sci. USA 74:5463-5467)) was used to sequence the ACC synthase cDNA clones for both geranium and rose.
- This method employed the DELTA Taq DNA polymerase protocol developed in the present inventor's laboratory (Ranu, R.S., (1995), Biotechniques 75:390-395) or Thermo Sequenase® (Amersham, Inc.). Based on the analysis of the DNA sequence results, the ACC synthase cDNA clones were classified into three classes belonging to two groups for geranium: GronpJ
- Class 1 pPHSacc41 [SEQ ID NO:l]was 1945 bp in length with an open reading frame (ORF) of 1446 encoding a polypeptide of 52.2 kDa for geranium;
- Class 2 pPHSacc44 [SEQ ID NO:2] was 2678 bp in length with an ORF of 1446 bp encoding a 54.2 kDa for geranium;
- Class 3 pPHSacc49 [SEQ ID NO:3] was 1893 bp in length with an ORF of 1470 bp encoding a 55.1 kDa polypeptide for geranium;
- Clone pPHSacc44 was unusual in several respects. First, it is 780 bp longer than clone 41. Second it has two distinct poly A signal sequences and polyA "tails" separated by 780 bases of 3' regulatory sequence which are present in genomic DNA. Thus, clone pPHSacc44 appears to include two separate regulatory regions 3' from coding sequence. Several additional features of these clones and several related clones which include some noteworthy areas as described below. Group I clones included a stop codon (TAG) just before the first AUG codon; the group II clone had a stop codon (TGA) 21 bp upstream (for geranium) of the first AUG.
- TAG stop codon
- TGA stop codon
- Clone pPHSacc44 had an "extra" 780 bp after a first short (22 bp) 3'-poly(A) tail. Both the poly(A) signal and poly(A) tail were present twice, at the normal 3' untranslated region (3'UTR) and in the extra 3'UTR for it. For rose, the clone included two stop codons on the 5' end of the untranslated region at positions 169 and 178. The regular start codon is at position 271 and the regular stop codon is at position 1711.
- Antibody probes were prepared for screening a cDNA expression library and for subsequent detection of ACC synthase gene products from plant cell extracts and for protein expressed from the cloned ACC synthase DNA. Based on the sequence alignment data from tomato, three peptides with largest stretches of amino acid sequence homology were selected.
- Peptide #1075 derived from the carboxy-terminus contained 35 amino acid residues as follows: NVSPGSSFLCSEPGWFRVCFANMDNATLDVALNRI [SEQ ID NO: 11 ]
- Peptide #1076, derived from the amino terminus contained 33 amino acids as follows:
- peptides were used to immunize rabbits.
- a preimmune serum sample was obtained.
- rabbits received two intramuscular (im) injections of 0.35 ml of a 1 :1 emulsion of each peptide in incomplete Freund's adjuvant at 100 ⁇ g/ml.
- im intramuscular
- the day 19 im protocol was repeated.
- each rabbit received a booster injection (im) with the same peptide emulsion as on day 19.
- the rabbits were bled, and serum was prepared.
- Western blot analysis of antisera with the three peptides showed the presence of antibodies against each of the three peptides and strong signals indicating immunization was successful.
- Preimmune sera were negative.
- the reaction mixture (100 ⁇ l) contained Tris-HCl (pH7.9), 40mM; MgCl 2 , 6mM; DTT, lOmM; spermidine, 2mM; m 7 G ⁇ ppG, ImM; ATP, CTP and UTP, 0.5mM each; GTP, 25 ⁇ M; Rnasin® (RNase inhibitor), 120 units; DNA template, 1-2 ⁇ g; and T 3 RNA polymerase, 50 units, as described in the inventor's publications. Samples were incubated at 37°C for 20 minutes. The GTP concentration in reaction mixture was raised to 0.5mM, and incubation was continued for one hour. Aliquots (3-5 ⁇ l) of each reaction mixture were withdrawn and subjected to agarose gel (1.2%) electrophoresis to determine the quality and efficiency of transcript synthesis. The analysis of transcript showed expected size of RNA from each clone.
- the in vitro transcripts from each clone were then translated at high efficiency using rabbit reticulocyte lysates as described by the present inventor (Ranu, R.S., et al, 1979, Meth. Enzymol. (50:459-484) except that they were made mRNA-dependent by treatment with micrococcal ribonuclease.
- the in vitro translation products were immunoprecipitated with each of the three antisera described above or with a mixture of the antisera.
- the method used for immunoprecipitation and detection of ACC synthase protein was by Western blotting as described by the present inventor and colleagues in 1989 and recently published (Ranu, R.S., et al, (1996) Gene Expression 5:143-153).
- Translation products detected from each cloned ACC synthase gene was the size expected based on the size of the ORF of each clone.
- the in vitro translation product comigrate with the in vivo product upon gel electrophore
- petioles from very young immature leaves from actively growing plants of Pelargonium hmlorum cv Samba were harvested and sterilized in 15% clorox for 15 minutes. They were then thoroughly rinsed with sterile distilled water (four times). The petioles were cut into 4-5mm segments and cultured on modified MS medium as further explained in A Revised Medium For Rapid Growth And Bioassys With Tabacco Tissue Cultures, Murashige T. and Skoog, F., Physiologia Plantarum 15,473-497 (1962).
- Modifications consist of one half concentration of major salts and pyridoxine HC1, lmg/liter; nicotinic acid 1 mg/liter; and thiamine HC1 lOmg/liter.
- the medium used contained 5 ⁇ M BAP and
- pPHSacc41 was cut with Not I; the staggered ends were filled-in with dGTP and dCTP using Kelnow DNA polymerase The other end was cut with Bam HI for ligation into an agrobacterium binary vector in reverse orientation.
- the vector was prepared for ligation using HP A I and Baml.
- the ligated vector (with PHSacc41 in reverse orientation) was used to transform agrobacterium tumefaciens 2760.
- the petiole explants were cocultivated with agrobacterium for 5-10 minutes. After several days of cocultivation, agrobacterium cells were killed in the presence of cefotaxime (400 ⁇ g/ml) and Kananeycin (200 ⁇ g/ml). After about two weeks selection for transformants was continued. Ultimately, the transformed plants will be grown and tested for their various properties to determine which had successfully achieved the desired ace synthase modification. The selected genetically altered plants will be used to produce a new variety or line of plants wherein the alteration is stably transmitted from generation to generation.
- cefotaxime 400 ⁇ g/ml
- Kananeycin 200 ⁇ g/ml
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU48929/97A AU4892997A (en) | 1996-10-01 | 1997-09-30 | 1-aminocyclopropane-1-carboxylate synthase genes from (pelargonium) and (rosa) to control ethylene levels in geraniums and roses |
US09/171,482 US6184449B1 (en) | 1996-10-01 | 1997-09-30 | 1-Aminocyclopropane-1-carboxylate synthase genes from rosa to control ethylene levels in roses |
CA002267074A CA2267074A1 (en) | 1996-10-01 | 1997-09-30 | 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium and rosa to control ethylene levels in geraniums and roses |
EP97911604A EP0961777A1 (en) | 1996-10-01 | 1997-09-30 | 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium and rosa to control ethylene levels in geraniums and roses |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/724,194 US5824875A (en) | 1996-10-01 | 1996-10-01 | 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium |
US08/724,194 | 1996-10-01 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/724,194 Continuation-In-Part US5824875A (en) | 1996-10-01 | 1996-10-01 | 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/171,482 A-371-Of-International US6184449B1 (en) | 1996-10-01 | 1997-09-30 | 1-Aminocyclopropane-1-carboxylate synthase genes from rosa to control ethylene levels in roses |
US09/776,529 Continuation US20020083484A1 (en) | 1996-10-01 | 2001-02-02 | 1-aminocyclopropane-1-carboxylate synthase gene from Rosa to control ethylene levels in roses |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998014465A1 true WO1998014465A1 (en) | 1998-04-09 |
Family
ID=24909426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/017644 WO1998014465A1 (en) | 1996-10-01 | 1997-09-30 | 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium and rosa to control ethylene levels in geraniums and roses |
Country Status (5)
Country | Link |
---|---|
US (3) | US5824875A (en) |
EP (1) | EP0961777A1 (en) |
AU (1) | AU4892997A (en) |
CA (1) | CA2267074A1 (en) |
WO (1) | WO1998014465A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000012714A1 (en) * | 1998-08-31 | 2000-03-09 | The University Of Queensland | A novel plant promoter and uses therefor |
WO2001085754A1 (en) * | 2000-05-09 | 2001-11-15 | Colorado State University Through Its Agent Colorado State University Research Foundation | Plant promoter |
WO2002055739A3 (en) * | 2001-01-15 | 2003-04-03 | Cytyc Corp | Nucleic acid extraction solution and use thereof |
WO2005019460A2 (en) * | 2003-08-18 | 2005-03-03 | Sungene Gmbh | Promoters for the expression of genes in tagetes |
WO2011041796A1 (en) * | 2009-10-02 | 2011-04-07 | Pioneer Hi-Bred International, Inc. | Down-regulation of acc synthase for improved plant performance |
WO2011139431A1 (en) * | 2010-05-06 | 2011-11-10 | Pioneer Hi-Bred International, Inc. | Maize acc synthase 3 gene and protein and uses thereof |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6723839B1 (en) | 1996-10-01 | 2004-04-20 | Colorado State University Through Its Agent Colorado State University Research Foundation | Partial gene sequence from pelargonium to control ethylene levels in geraniums |
US5824875A (en) * | 1996-10-01 | 1998-10-20 | Colorado State University Through Its Agent Colorado State University Research Foundation | 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium |
CN1354797A (en) | 1999-02-16 | 2002-06-19 | 森尼斯科公司 | DNA encoding plant lipase, transgenic plants and method for controlling senescence in plants |
US7074556B2 (en) * | 1999-03-02 | 2006-07-11 | Invitrogen Corporation | cDNA synthesis improvements |
US6538182B1 (en) * | 1999-07-06 | 2003-03-25 | Senesco, Inc. | DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
CN1339506A (en) * | 2000-08-23 | 2002-03-13 | 上海博德基因开发有限公司 | New polypeptide-human poly adenyl acid binding protein 20.13 and polynucleotide for encoding such polypeptide |
CA2420555C (en) * | 2000-08-24 | 2012-10-23 | Jeffrey F. Harper | Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
US20040101841A1 (en) * | 2001-05-09 | 2004-05-27 | Ranu Rajinder S. | Plant promoter |
US20030186278A1 (en) * | 2001-12-11 | 2003-10-02 | Joseph Mitchell | Methods for the identification of inhibitors of 1-aminocyclopropane-1-carboxylate oxidase expression or activity in plants |
US20040152072A1 (en) * | 2002-07-30 | 2004-08-05 | Invitrogen Corporation | Reverse transcription |
CA2529658C (en) * | 2003-06-23 | 2017-09-12 | Pioneer Hi-Bred International, Inc. | Engineering single-gene-controlled staygreen potential into plants |
CA2645772A1 (en) * | 2007-12-05 | 2009-06-05 | Tagawa Greenhouse Enterprises, Llc | Collapsible support apparatus and methods |
GB2523050B (en) * | 2012-11-21 | 2020-12-30 | Agilent Technologies Inc | Superficially porous hybrid monoliths with ordered pores and methods of making and using same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5416250A (en) * | 1989-12-12 | 1995-05-16 | Agritope, Inc. | Genetic control of ethylene biosynthesis in plants using S-adenosylmethionine hydrolase |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
US4468464A (en) | 1974-11-04 | 1984-08-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically functional molecular chimeras |
US5272065A (en) | 1983-10-20 | 1993-12-21 | Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5208149A (en) | 1983-10-20 | 1993-05-04 | The Research Foundation Of State University Of New York | Nucleic acid constructs containing stable stem and loop structures |
US4740463A (en) | 1984-04-13 | 1988-04-26 | Massachusetts Institute Of Technology | Methods and artificial genes for antagonizing the function of an oncogene |
US4782022A (en) * | 1984-06-04 | 1988-11-01 | Lubrizol Genetics, Inc. | Nitrogen fixation regulator genes |
US5453566A (en) | 1986-03-28 | 1995-09-26 | Calgene, Inc. | Antisense regulation of gene expression in plant/cells |
US5107065A (en) | 1986-03-28 | 1992-04-21 | Calgene, Inc. | Anti-sense regulation of gene expression in plant cells |
US5123951A (en) * | 1986-03-31 | 1992-06-23 | Rhone-Poulenc Nederland B.V. | Synergistic plant growth regulator compositions |
US5565347A (en) | 1986-06-10 | 1996-10-15 | Calgene, Inc. | Transformation and foreign gene expression with plant species |
US4962028A (en) * | 1986-07-09 | 1990-10-09 | Dna Plant Technology Corporation | Plant promotors |
US4801540A (en) | 1986-10-17 | 1989-01-31 | Calgene, Inc. | PG gene and its use in plants |
DK0426641T3 (en) * | 1989-10-31 | 2000-10-23 | Monsanto Co | Promoter for transgenic plants |
US6207881B1 (en) | 1990-09-10 | 2001-03-27 | The United States Of America As Represented By The Department Of Agriculture | Control of fruit ripening through genetic control of ACC synthase synthesis |
ATE256741T1 (en) | 1993-07-01 | 2004-01-15 | California Inst Of Techn | PLANTS WITH MODIFIED RESPONSE TO ETHYLENE |
US5689055A (en) | 1993-07-01 | 1997-11-18 | California Institue Of Technology | Plants having modified response to ethylene |
US5674731A (en) | 1995-04-27 | 1997-10-07 | Life Technologies, Inc. | Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid |
US5824875A (en) * | 1996-10-01 | 1998-10-20 | Colorado State University Through Its Agent Colorado State University Research Foundation | 1-aminocyclopropane-1-carboxylate synthase genes from pelargonium |
-
1996
- 1996-10-01 US US08/724,194 patent/US5824875A/en not_active Expired - Fee Related
-
1997
- 1997-09-30 EP EP97911604A patent/EP0961777A1/en not_active Withdrawn
- 1997-09-30 CA CA002267074A patent/CA2267074A1/en not_active Abandoned
- 1997-09-30 US US09/171,482 patent/US6184449B1/en not_active Expired - Fee Related
- 1997-09-30 AU AU48929/97A patent/AU4892997A/en not_active Abandoned
- 1997-09-30 WO PCT/US1997/017644 patent/WO1998014465A1/en not_active Application Discontinuation
-
2001
- 2001-02-02 US US09/776,529 patent/US20020083484A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5416250A (en) * | 1989-12-12 | 1995-05-16 | Agritope, Inc. | Genetic control of ethylene biosynthesis in plants using S-adenosylmethionine hydrolase |
Non-Patent Citations (10)
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000012714A1 (en) * | 1998-08-31 | 2000-03-09 | The University Of Queensland | A novel plant promoter and uses therefor |
US7745603B1 (en) | 1998-08-31 | 2010-06-29 | The University Of Queensland | Plant promoter and uses therefor |
WO2001085754A1 (en) * | 2000-05-09 | 2001-11-15 | Colorado State University Through Its Agent Colorado State University Research Foundation | Plant promoter |
WO2002055739A3 (en) * | 2001-01-15 | 2003-04-03 | Cytyc Corp | Nucleic acid extraction solution and use thereof |
US6939672B2 (en) | 2001-01-15 | 2005-09-06 | Cytyc Corporation | Nucleic acid extraction solution and use thereof |
WO2005019460A2 (en) * | 2003-08-18 | 2005-03-03 | Sungene Gmbh | Promoters for the expression of genes in tagetes |
WO2005019460A3 (en) * | 2003-08-18 | 2005-07-21 | Sungene Gmbh & Co Kgaa | Promoters for the expression of genes in tagetes |
WO2011041796A1 (en) * | 2009-10-02 | 2011-04-07 | Pioneer Hi-Bred International, Inc. | Down-regulation of acc synthase for improved plant performance |
WO2011139431A1 (en) * | 2010-05-06 | 2011-11-10 | Pioneer Hi-Bred International, Inc. | Maize acc synthase 3 gene and protein and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
US5824875A (en) | 1998-10-20 |
US6184449B1 (en) | 2001-02-06 |
US20020083484A1 (en) | 2002-06-27 |
CA2267074A1 (en) | 1998-04-09 |
EP0961777A1 (en) | 1999-12-08 |
AU4892997A (en) | 1998-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6184449B1 (en) | 1-Aminocyclopropane-1-carboxylate synthase genes from rosa to control ethylene levels in roses | |
US8822761B2 (en) | Genes for enhancing nitrogen utilization efficiency in crop plants | |
US20100115662A1 (en) | Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants | |
US9518266B2 (en) | Maize genes for controlling plant growth and organ size and their use in improving crop plants | |
US9024141B2 (en) | Maize ERECTA genes for improving plant growth, transpiration, efficiency and drought tolerance in crop plants | |
AU727323B2 (en) | Novel ACC synthase genes | |
JPH11276181A (en) | Transcription factor controlling phenyl propanoid biosynthesis route | |
US8269066B2 (en) | Nitrate reductases from red algae, compositions and methods of use thereof | |
US6723839B1 (en) | Partial gene sequence from pelargonium to control ethylene levels in geraniums | |
WO2008029942A1 (en) | Use of activated cytokinin-biosynthesizing enzyme gene | |
WO2006060699A9 (en) | Methods of increasing seed yield | |
WO1993006220A1 (en) | Tryptophan analogues as selective agents in the transformation of plants and plant cells | |
AU2013202738C1 (en) | Manipulation of organic acid biosynthesis and secretion (4) | |
AU2012216840B2 (en) | Manipulation of organic acid biosynthesis and secretion (3) | |
AU2011211347B2 (en) | Modification of plant and seed development and plant responses to stresses and stimuli (3) | |
AU2004228859B2 (en) | Manipulation of organic acid biosynthesis and secretion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page |
Free format text: ADD INID NUMBER (63) "RELATED BY CONTINUATION (CON) OR CONTINUATION-IN-PART (CIP) TO EARLIER APPLICATION" WHICH WAS INADVERTENTLY OMITTED FROM THE FRONT PAGE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09171482 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2267074 Country of ref document: CA Ref country code: KE Ref document number: 1997US 9717644 Kind code of ref document: A Format of ref document f/p: F Ref country code: CA Ref document number: 2267074 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997US9717644 Country of ref document: KE |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/003060 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997911604 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998516810 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997911604 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997911604 Country of ref document: EP |